Pharma Price & Availability Intelligence Report – India E-Pharmacy 2025

Introduction

The Indian online pharmacy market continues to expand at double-digit growth, driven by rising chronic illnesses, rapid urban adoption, and the shift toward digital healthcare. In 2025, platforms like 1mg, PharmEasy, NetMeds and MrMed have become essential retail channels for consumers as well as pharma brands.

This research and data intelligence report, powered by Actowiz Solutions, provides a detailed analysis of pricing trends, discount fluctuations, stock availability, and delivery ETA patterns across India’s leading e-pharmacy platforms.

Our insights help:

• Pharma manufacturers
• Distributors
• Healthcare brands
• Hospital procurement teams
• D2C medicine brands

understand real-time market movements and improve pricing decisions, channel strategies and supply-chain planning.

India E-Pharmacy Market Overview 2025

India’s e-pharmacy sector is expected to cross USD 3.4 billion in 2025, growing steadily due to:

Key Growth Drivers

• More chronic patients requiring monthly refill cycles
• Consumer preference for home delivery
• Competitive pricing and discounts
• Wider assortment availability
• Quick delivery options in top cities

Platforms like 1mg and PharmEasy dominate Tier 1 metros, while MrMed is becoming popular for specialty medicines and critical-care drug delivery.

Actowiz Solutions analyzed real-time data across 4 platforms, including:

• Selling price
• MRP variations
• Discount volatility
• Stock status
• Availability by pin code
• Delivery ETA
• SKU visibility

Pricing Comparison Across Platforms

Pricing remains the biggest differentiator. Actowiz’s data engine captures price shifts every few minutes across India’s leading pharmacies.

General Observations

Price variations between platforms range from 12–28% for OTC and chronic drugs.

Specialty drugs show very low price fluctuation on MrMed.

PharmEasy and NetMeds offer the highest discount volatility, especially during campaigns.

Sample Pricing Data (Illustrative)

Key Insight: NetMeds tends to undercut competitor prices for chronic medicines, while 1mg maintains stable pricing in most regions.

Discount Volatility Analysis

Discounts vary highly across seasons, campaigns, and supply availability.

Actowiz Solutions tracked discount fluctuations for 90 days, showing:

• OTC categories show highest volatility, especially immunity, pain relief and supplements.
• PharmEasy frequently runs flash discount drops, especially on high-demand brands.
• NetMeds shows city-based discount targeting during weekends.
• 1mg maintains the most stable discount structure with controlled couponing.

Sample Discount Trend Data (Illustrative)

Insight: PharmEasy fluctuates aggressively, sometimes offering 30–32% during its monthly sales, impacting brand price integrity.

Availability & Stock Status Tracking

Stockouts are a major issue for both chronic and acute medicines, especially in metro cities.

Actowiz Solutions found:

• 1mg shows the lowest OOS rate, especially for chronic medicines.
• NetMeds sees maximum stockouts during campaigns.
• MrMed maintains strong availability of specialty and oncology drugs.
• Under-stock issues appear during weekends on all platforms.

Sample OOS Dataset (Illustrative)

Insight: Critical-care drugs show higher stability on MrMed due to specialized procurement.

Delivery ETA & Logistics Benchmarking

Delivery speed plays a crucial role in platform preference.

Based on our tracking across 20+ cities:

• 1mg offers the fastest ETA in metros (3–6 hours).
• PharmEasy and NetMeds average 6–18 hours, depending on warehouse proximity.
• MrMed specializes in next-day delivery for high-value medicines.

Sample Delivery ETA Data

Category-Wise Insights & Market Behavior

Using continuous data from Actowiz Solutions’ crawling engines, we mapped how different pharma categories behave across 1mg, PharmEasy, NetMeds and MrMed.

a. Chronic Medicines (Diabetes, Hypertension, Thyroid)

• Most stable in pricing and discounts.
• Lowest OOS rate on 1mg and PharmEasy.
• NetMeds offers the most competitive prices.
• High-demand SKUs often show micro-level discount shifts, especially during morning hours.

b. Vitamins & Supplements

• Maximum discount volatility (up to 40% swings).
• Frequent flash sale triggers during weekends.
• Seasonal spikes during winter and flu waves.
• Heavy competition driven by D2C nutrition brands.

c. Pain Relief & Flu Medicines

• Surges during monsoon and winter.
• Delivery ETA reduces during peak outbreaks.
• Pricing remains mostly uniform, except for coupon variance.

d. Specialty Medicines (Oncology, Immunotherapy, Rare Diseases)

• MrMed leads in availability and fast procurement.
• Discounts are minimal (2–5%) due to regulatory constraints.
• Supply chain reliability is the biggest differentiator.

Pincode-Level Availability Insights

Actowiz collected hyperlocal data across 980+ pincodes in Tier-1, Tier-2 and Tier-3 cities.

Key Findings

• Tier-1 cities show strong availability & faster ETA on all platforms.
• Tier-2 cities see increased stockouts, especially on NetMeds.
• Tier-3 regions depend heavily on 1mg for chronic and OTC medicine availability.
• MrMed delivers specialty medicines pan-India but with next-day ETA.

Sample Pincode-Level Dataset

Insight: Platforms optimize SKU sorting based on regional disease patterns and warehouse distribution.

Competitive Benchmarking: Key Platform Strengths

1mg

Strengths:

• Fastest delivery
• Lowest OOS rate
• Strong catalog depth
• Stable pricing

Weaknesses:

• Discounting not as aggressive as others

PharmEasy

Strengths:

• Highest discount intensity
• Aggressive promotions
• Strong metro distribution

Weaknesses:

• Frequent stockouts during peak sale periods

NetMeds

Strengths:

• Lowest comparative pricing
• Strong offers during festive seasons
• Wide range of generic alternatives

Weaknesses:

• Delivery ETA fluctuates heavily
• Stock inconsistency in Tier-2 cities

MrMed

Strengths:

• Best for critical-care & specialty medicines
• Reliable nationwide delivery
• High-value drug availability

Weaknesses:

• Minimal discounts
• Higher base pricing compared to general platforms

Market Intelligence Trends to Watch in 2025

Based on Actowiz Solutions’ data signals, here are the emerging patterns:

a. Strong Shift to Chronic Subscriptions

Platforms will push automated refill cycles and subscription models for stable revenue.

b. Increasing Flash Discounts for Engagement

PharmEasy and NetMeds will intensify algorithmic discounting to boost daily active buyers.

c. Hyperlocal Medicine Availability Will Improve

Expect micro-warehouses and dark stores for faster fulfillment.

d. Regulatory Oversight on Online Discounting

Government may introduce caps on OTC discounting to protect retail pharmacy networks.

e. Specialty Medicines Will Move More Online

MrMed and 1mg will expand oncology, biologics & rare-disease coverage.

Why Pharma Brands Use Actowiz Solutions

Actowiz Solutions is the trusted data partner for pharma companies, distributors and digital health businesses.

Our Capabilities

• India-wide pincode-level availability tracking
• Real-time price & discount data scraping
• Flash sale & volatility monitoring
• Stockout prediction using intelligence signals
• Delivery ETA benchmarking
• Competitor comparison dashboards
• SKU alignment across platforms
• API-based live data delivery

Our systems crawl millions of product pages daily across India’s top e-pharmacies with enterprise-level accuracy.

Sample Output from Actowiz Pharma Intelligence Dashboard

Price Intelligence Widget

• Real-time MRP vs selling price
• Discount curve by platform
• Hourly trend visualization

Availability Monitor

• SKU-wise in-stock / out-of-stock
• City-scale heatmaps
• Supply chain disruption flags

Delivery ETA Comparator

• Fastest platform by pincode
• Weekend vs weekday performance
• Real-time ETA accuracy tracking

Alert System

• Price drop alerts
• Sudden stockouts
• High-demand medicine surge signals

This helps procurement teams, brand managers and supply chain heads act on accurate, real-time insights instead of assumptions.

Conclusion: What This Means for the Pharma Industry

By tracking the top four platforms — 1mg, PharmEasy, NetMeds and MrMed — Actowiz Solutions gives the industry a clear view of India’s fast-changing e-pharmacy landscape.

Key takeaways:

• Pricing variations remain high across platforms.
• Discount volatility impacts brand pricing stability.
• Stockouts continue in Tier-2 and Tier-3 regions.
• Delivery ETA is rapidly improving due to micro-fulfillment centers.
• Specialty medicine distribution remains dominated by MrMed.

In 2025 and beyond, the brands that rely on real-time price, availability and delivery intelligence will lead the market.